PDE1-IN-4 is a potent and selective phosphodiesterase-1 (PDE1) inhibitor with IC50 values of 10, 145, and 354 nM for PDE1C, PDE1A, and PDE1B, respectively; it inhibits TGF-β1-induced differentiation of human lung fibroblasts and exerts antifibrotic effects by modulating cAMP and cGMP levels; it can be used in the study of idiopathic pulmonary fibrosis (IPF).